- Record: found
- Abstract: not found
- Article: not found
Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
2003-11-11
Aged, Biological Markers, C-Reactive Protein, analysis, Cardiovascular Diseases, epidemiology, prevention & control, Cholesterol, LDL, blood, Double-Blind Method, Female, Fluorobenzenes, therapeutic use, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lovastatin, Male, Metabolic Syndrome X, drug therapy, Middle Aged, Multicenter Studies as Topic, Pyrimidines, Randomized Controlled Trials as Topic, Research Design, Risk Factors, Sulfonamides
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
Aged,Biological Markers,C-Reactive Protein,analysis,Cardiovascular Diseases,epidemiology,prevention & control,Cholesterol, LDL,blood,Double-Blind Method,Female,Fluorobenzenes,therapeutic use,Humans,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Lovastatin,Male,Metabolic Syndrome X,drug therapy,Middle Aged,Multicenter Studies as Topic,Pyrimidines,Randomized Controlled Trials as Topic,Research Design,Risk Factors,Sulfonamides
Aged, Biological Markers, C-Reactive Protein, analysis, Cardiovascular Diseases, epidemiology, prevention & control, Cholesterol, LDL, blood, Double-Blind Method, Female, Fluorobenzenes, therapeutic use, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lovastatin, Male, Metabolic Syndrome X, drug therapy, Middle Aged, Multicenter Studies as Topic, Pyrimidines, Randomized Controlled Trials as Topic, Research Design, Risk Factors, Sulfonamides